Nalena Review
Nalena is no longer available as we reviewed it, so this page is kept for reference.
Nalena: No longer offers GLP-1s; the brand now sells an ED treatment. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Nalena was a women-focused telehealth service that sold compounded semaglutide and tirzepatide. It no longer offers GLP-1s: its site now presents Nalena as a sister brand of Vigo MD and sells a single erectile-dysfunction tablet, with no mention of semaglutide, tirzepatide or weight loss. There is no GLP-1 program left to price or rank.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Nalena
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Nalena at a glance
- Type
- GLP-1 telehealth provider
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Nalena
Each dimension is scored algorithmically from Nalena’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10Nalena no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
6.9/10Nalena's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence, so weigh the clinical support carefully.
User Experience15%
8.3/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
8.4/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
9.7/10Nalena treats patients in all 50 states.
Support10%
7.3/10Nalena provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Nalena review
Last checked August 2026- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What we like
- Review page kept live so former patients get a straight answer
Watch-outs
- No longer sells semaglutide, tirzepatide or any weight-loss treatment
- The site now sells one ED tablet under a shared brand with Vigo MD
- No published route for former GLP-1 patients to refill or reach their prescriber
Nalena no longer does weight loss: it is now an ED brand
If you came here for Nalena's compounded GLP-1 program for women, it is gone. Until mid-2026 Nalena did one narrow thing well: it bundled compounded semaglutide or tirzepatide with the consult and shipping into a single all-in monthly price, with no membership and no separate visit fee. As of November 2026, none of that is left. The homepage now reads "Nalena × VIGO MD · Sister telehealth brands, one physician network" and sells a single erectile-dysfunction product, a physician-prescribed sublingual tablet billed monthly.
Across the whole homepage the words semaglutide, tirzepatide, GLP-1 and weight appear exactly zero times, whether in the navigation, the treatments section or the FAQ. A weight-loss service does not describe itself without ever using the word weight. The one price on the page belongs to that ED tablet.
What to do if you were a patient
There is no published route on the site to refill a GLP-1 prescription or reach the clinician who wrote it; support is a single email address. If you were mid-treatment, the priority is continuing care somewhere else rather than stopping abruptly: a GLP-1 dose should be continued or tapered on clinical advice, not interrupted because a provider changed its business. Ask your new provider to request your records, and if you have a pharmacy name on an old label, contact that pharmacy directly, since the dispensing pharmacy is a separate business from the brand that arranged the visit.
Is Nalena still around?
The company still exists, but the weight-loss program does not. Nalena is excluded from every WLR ranking and best-of list, carries no outbound link, and the alternatives shown on this page are all currently operating and were price-checked recently. When you compare them, look at what each bundles as well as what it charges. An all-in rate like the one Nalena used to offer is worth more than a lower headline that adds the consult, the shipping or the dose increase back on at checkout. Our scoring methodology explains how we weigh those inclusions.
The Bottom Line
Nalena is no longer available as we reviewed it, so this page is kept for reference.
Nalena might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nalena review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.